{"schema_version":"secwatch.filing_event.v1","accession":"0001802457-26-000021","form_type":"8-K","ticker":"ORGN","cik":"0001802457","company_name":"Origin Materials, Inc.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.933978+00:00","generated_at":"2026-05-15T00:21:19.523080+00:00","sec_items":["2.05","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Origin Materials board approves dissolution, liquidation; CEO steps down; workforce cut 59%","bullets":["Board approved plan of dissolution and liquidation, subject to stockholder vote at special meeting.","Workforce reduced ~59% (~$14M annual savings); expects ~$2.1M restructuring charges in Q2 2026.","CEO John Bissell steps down effective May 1, 2026; CFO Matt Plavan appointed Interim CEO.","Interim CEO Plavan and General Counsel Joshua Lee receive 25% salary increase and retention bonuses ($183,618 and $153,696).","Company intends to sell technology and assets to maximize shareholder value during wind down."],"urls":{"canonical":"https://secwatch.observer/filing/0001802457-26-000021","json":"https://secwatch.observer/filing/0001802457-26-000021.json","markdown":"https://secwatch.observer/filing/0001802457-26-000021.md","text":"https://secwatch.observer/filing/0001802457-26-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/orgn-20260501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:21:19.523080+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"06e0ab8278","claim":"John Bissell departed as Chief Executive Officer at Origin Materials, Inc..","evidence_excerpt":"John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","confidence":0.95},{"claim_id":"c566906b0e","claim":"Matt Plavan was appointed as Interim Chief Executive Officer at Origin Materials, Inc..","evidence_excerpt":"Matt Plavan, age 62, our Chief Financial Officer and Chief Operating Officer has been appointed Interim Chief Executive Officer, effective May 1, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","confidence":0.95},{"claim_id":"68edfb988c538d8e95a72bf56d701133e8f06b76","claim":"Origin Materials, Inc. announced a restructuring with charges of approximately $2.1 million (approximately 59%).","evidence_excerpt":"its workforce by approximately 59%, resulting in an approximately $14.0 million decrease in annual operating expenses. Origin anticipates that it will incur approximately $2.1 million in restructuring charges in connection with the workforce reduction, primarily consisting of cash expenditures of approximately $2.1 million for severance and benefits costs.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001493152-26-026544","ticker":"LIXT","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2026-06-01T12:55:34+00:00","headline":"Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board","event_type":"other_material","sec_items":["5.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026544","json":"https://secwatch.observer/filing/0001493152-26-026544.json","markdown":"https://secwatch.observer/filing/0001493152-26-026544.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/form8-k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","comparable_excerpt":"On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm"}},{"accession":"0001829126-26-005831","ticker":"FXAC","company_name":"FortuneX Acquisition Corp","filed_at":"2026-05-29T21:32:49+00:00","headline":"FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-005831","json":"https://secwatch.observer/filing/0001829126-26-005831.json","markdown":"https://secwatch.observer/filing/0001829126-26-005831.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/0001829126-26-005831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/fortunexacq_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","comparable_excerpt":"Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/0001829126-26-005831-index.htm"}},{"accession":"0001750155-26-000080","ticker":"CWBHF","company_name":"Charlotte's Web Holdings, Inc.","filed_at":"2026-06-01T21:13:23+00:00","headline":"Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment","event_type":"other_material","sec_items":["5.02","5.07","8.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001750155-26-000080","json":"https://secwatch.observer/filing/0001750155-26-000080.json","markdown":"https://secwatch.observer/filing/0001750155-26-000080.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/0001750155-26-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/cweb-20260528.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","comparable_excerpt":"Effective May 28, 2026 (the “Effective Date”), the board of directors of Charlotte’s Web Holdings, Inc. (the “Company”), appoint James Jeffery Raborn to the Company’s board of directors","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/0001750155-26-000080-index.htm"}},{"accession":"0001185185-26-002273","ticker":"DGAC","company_name":"DISCIPLINED GROWTH ACQUISITION Corp","filed_at":"2026-06-01T20:15:34+00:00","headline":"Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-26-002273","json":"https://secwatch.observer/filing/0001185185-26-002273.json","markdown":"https://secwatch.observer/filing/0001185185-26-002273.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/dgac8k052926.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","comparable_excerpt":"John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman and Jay Gettenberg (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm"}},{"accession":"0001193125-26-249692","ticker":"ELOX","company_name":"Eloxx Pharmaceuticals, Inc.","filed_at":"2026-06-01T11:00:19+00:00","headline":"Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors","event_type":"other_material","sec_items":["3.02","3.03","5.03","5.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249692","json":"https://secwatch.observer/filing/0001193125-26-249692.json","markdown":"https://secwatch.observer/filing/0001193125-26-249692.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/0001193125-26-249692-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/d261568d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","comparable_excerpt":"the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/0001193125-26-249692-index.htm"}},{"accession":"0001104659-26-068521","ticker":"FDXF","company_name":"FedEx Freight Holding Company, Inc.","filed_at":"2026-06-01T10:46:03+00:00","headline":"FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed","event_type":"other_material","sec_items":["1.01","2.03","3.03","5.03","5.01","5.02","5.05","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068521","json":"https://secwatch.observer/filing/0001104659-26-068521.json","markdown":"https://secwatch.observer/filing/0001104659-26-068521.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/tm2615735d2_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","comparable_excerpt":"each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm"}},{"accession":"0001171843-26-003809","ticker":"CRMT","company_name":"AMERICAS CARMART INC","filed_at":"2026-05-29T21:30:17+00:00","headline":"America's Car-Mart forms special committee for strategic alternatives; appoints new independent director","event_type":"other_material","sec_items":["1.01","5.02","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003809","json":"https://secwatch.observer/filing/0001171843-26-003809.json","markdown":"https://secwatch.observer/filing/0001171843-26-003809.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/0001171843-26-003809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/f8k_052926.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","comparable_excerpt":"On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/0001171843-26-003809-index.htm"}},{"accession":"0001636282-26-000056","ticker":"SYRE","company_name":"Spyre Therapeutics, Inc.","filed_at":"2026-05-29T20:45:58+00:00","headline":"Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001636282-26-000056","json":"https://secwatch.observer/filing/0001636282-26-000056.json","markdown":"https://secwatch.observer/filing/0001636282-26-000056.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000056/0001636282-26-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000056/syre-20260527.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","comparable_excerpt":"In addition, effective as of May 27, 2026, Peter Harwin resigned from the Board.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000056/0001636282-26-000056-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}